Response of a recurrent anaplastic meningioma to Bevacizumab

Maximilian J. A. Puchner, Volkmar H. Hans, Martin Glas, Ali Harati, Frauke Lohmann & Ulrich Herrlinger
Objective: Standard therapy for anaplastic meningiomas consists of surgery and radiotherapy. This treatment results in a median survival time of 15 months. Various attempts to treat those tumors by chemotherapeutic drugs failed. As meningiomas are highly vascularized tumors and produce high levels of[for full text, please go to the a.m. URL]